Halozyme Reports Fourth Quarter And Full-Year 2017 Results

Go back to Halozyme Reports Fourth Quarter And Full-Year 2017 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 68.99 --0 (-0%)
Previous Close $68.99    52 Week High $18.39 
Open $68.99    52 Week Low $6.96 
Day High $68.99    P/E N/A 
Day Low $68.99    EPS $-0.58 
Volume 35